CASC15 (cancer susceptibility 15; previously annotated as LINC00340) is a lncRNA with reported tumour suppressor properties in melanoma, neuroblastoma and acute leukaemia [70–72], which is also associated with higher survival probability in AML. Here, CASC15 is linked to acute myeloid leukemia.